Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 9

Results: 14

A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1079, doi. 10.1007/s40265-021-01547-5

By:

Gulati, Anil;
Choudhuri, Rajat;
Gupta, Ajay;
Singh, Saurabh;
Ali, S. K. Noushad;
Sidhu, Gursaran Kaur;
Haque, Parvez David;
Rahate, Prashant;
Bothra, Aditya R.;
Singh, Gyan P.;
Maheshwari, Sanjiv;
Jeswani, Deepak;
Haveri, Sameer;
Agarwal, Apurva;
Agrawal, Nilesh Radheshyam

Publication type:

Article

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.

Published in:

2021

By:

Lamb, Yvette N.

Publication type:

Correction Notice

Comment on: "Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry".

Published in:

2021

By:

Vuorio, Alpo;
Kovanen, Petri T.

Publication type:

Letter to the Editor

Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer.

Published in:

2021

By:

Kauffmann-Guerrero, Diego;
Kahnert, Kathrin;
Huber, Rudolf M.

Publication type:

Correction Notice

Comment on: "Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Haemodialysis".

Published in:

2021

By:

Descombes, Eric;
Hemett, Ould Maouloud;
Erard, Véronique;
Chuard, Christian

Publication type:

Letter to the Editor

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1065, doi. 10.1007/s40265-021-01534-w

By:

Vogelaers, Dirk;
Blot, Stijn;
Van den Berge, Andries;
Montravers, Philippe;
for the Abdominal Sepsis Study ('AbSeS') Group on behalf of the Trials Group of the European Society of Intensive Care Medicine;
Francois, Guy;
Labeau, Sonia;
Blot, Koen;
Deschepper, Mieke;
Antonelli, Massimo;
Lipman, Jeffrey;
Lamrous, Amin;
Pereyra, Cecilia;
Lipovestky, Fernando;
Koulenti, Despoina;
De Waele, Jan;
Rezende-Neto, Joao;
Cardenas, Yenny;
Vymazal, Tomas;
Fjeldsoee-Nielsen, Hans

Publication type:

Article

Lazertinib: First Approval.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1107, doi. 10.1007/s40265-021-01533-x

By:

Dhillon, Sohita

Publication type:

Article

Dasiglucagon: First Approval.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1115, doi. 10.1007/s40265-021-01531-z

By:

Blair, Hannah A.

Publication type:

Article

Correction to: Inclisiran: First Approval.

Published in:

2021

By:

Lamb, Yvette N.

Publication type:

Correction Notice

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1031, doi. 10.1007/s40265-021-01526-w

By:

Huntemann, Niklas;
Rolfes, Leoni;
Pawlitzki, Marc;
Ruck, Tobias;
Pfeuffer, Steffen;
Wiendl, Heinz;
Meuth, Sven G.

Publication type:

Article

Evinacumab: First Approval.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1101, doi. 10.1007/s40265-021-01516-y

By:

Markham, Anthony

Publication type:

Article

Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma.

Published in:

Drugs, 2021, v. 81, n. 9, p. 971, doi. 10.1007/s40265-021-01506-0

By:

Cui, Wanyuan;
Popat, Sanjay

Publication type:

Article

A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes.

Published in:

Drugs, 2021, v. 81, n. 9, p. 1003, doi. 10.1007/s40265-021-01499-w

By:

Andersen, Andreas;
Knop, Filip Krag;
Vilsbøll, Tina

Publication type:

Article

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.

Published in:

Drugs, 2021, v. 81, n. 9, p. 985, doi. 10.1007/s40265-021-01528-8

By:

Pérez-Jeldres, Tamara;
Alvarez-Lobos, Manuel;
Rivera-Nieves, Jesús

Publication type:

Article